|
1
|
Goldberg VE, Polyakova TY, Popova NO, Vysotskaya VV, Simolina EI, Dudnikova EA, Goncharova NM, Belevich YV, Tuzikova TP, Goldberg AV, Miroshnichenko LA, Udut EV, Simanina EV, Zyuz'kov GN, Zhdanov VV, Dygai AM. Mechanisms of Granulocytopoiesis Recovery Stimulation with Filgrastim in Breast Cancer Patients Receiving Chemotherapy. Bull Exp Biol Med 2018; 166:63-68. [PMID: 30450524 DOI: 10.1007/s10517-018-4290-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Indexed: 11/25/2022]
Abstract
We studied myelotoxicity of modern schemes of chemotherapy for breast cancer (docetaxel/doxorubicin and cyclophosphamide/doxorubicin/5-fluorouracil) towards granulocytopoiesis, the mechanisms determining the differences of hematological effects of these schemes, and the efficiency of correction of the observed changes with granulocyte CSF (filgrastim). Granulocytopoiesis stimulation with filgrastim during the treatment with docetaxel/doxorubicin combination was more pronounced than during cyclophosphamide/doxorubicin/5-fluorouracil therapy. The observed differences were found at all levels of granulocyte lineage organization (central and peripheral), which is related to different effects of the cytostatic substances used in the proposed protocols on the structures controlling hemopoiesis.
Collapse
Affiliation(s)
- V E Goldberg
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
| | - T Yu Polyakova
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
- National Research Tomsk State University, Tomsk, Russia
| | - N O Popova
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - V V Vysotskaya
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - E I Simolina
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - E A Dudnikova
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - N M Goncharova
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - Yu V Belevich
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - T P Tuzikova
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - A V Goldberg
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - L A Miroshnichenko
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - E V Udut
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - E V Simanina
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - G N Zyuz'kov
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - V V Zhdanov
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| | - A M Dygai
- Research Institute of Oncology, Tomsk Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia
| |
Collapse
|
|
2
|
Dygai AM, Zyuz'kov GN, Zhdanov VV, Udut EV, Gurto RV, Miroshnichenko LA, Simanina EV, Khrichkova TI, Stavrova LA, Chaikovsky AV, Artamonov AV, Bekarev AA, Madonov PG, Minakova MI, Markova TS. Potentiation of hemostimulating effects of erythropoietin with pegylated hyaluronate-endo-β-N-acetylhexosaminidase. Bull Exp Biol Med 2012; 153:684-8. [PMID: 23113258 DOI: 10.1007/s10517-012-1799-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Pegylated hyaluronate-endo-β-N-acetylhexosaminidase considerably potentiates the hemostimulating effects of erythropoietin due to intensification of proliferation and differentiation of erythroid precursors against the background of enhanced secretion of hemopoietins by nonadherent hemopoiesis-inducing environment cells and elevation of serum erythropoietin concentration. The use of the enzyme allows 10-fold reduction of the maximum effective erythropoietin dose.
Collapse
Affiliation(s)
- A M Dygai
- Siberian Division of the Russian Academy of Medical Sciences, Institute of Pharmacology, Tomsk, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
3
|
Effect of Hyaluronidase Immobilized Using Electron-Beam Synthesis Nanotechnology on Sensitivity of Progenitor Cells to Regulatory Factors. Bull Exp Biol Med 2011; 151:150-3. [DOI: 10.1007/s10517-011-1277-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|